Thorac Cardiovasc Surg Rep 2015; 04(01): 037-039
DOI: 10.1055/s-0035-1564065
Case Report: Cardiac
Georg Thieme Verlag KG Stuttgart · New York

An Integrated Approach to von Willebrand Disease and Surgical Myocardial Revascularization

Federica Jiritano
1   Department of Cardiac Surgery, Magna Graecia University, Catanzaro, Italy
,
Lucia Cristodoro
1   Department of Cardiac Surgery, Magna Graecia University, Catanzaro, Italy
,
Egidio Bevacqua
1   Department of Cardiac Surgery, Magna Graecia University, Catanzaro, Italy
,
Emanuele Malta
1   Department of Cardiac Surgery, Magna Graecia University, Catanzaro, Italy
,
Pasquale Mastroroberto
1   Department of Cardiac Surgery, Magna Graecia University, Catanzaro, Italy
› Author Affiliations
Further Information

Publication History

15 June 2015

16 July 2015

Publication Date:
18 September 2015 (online)

Abstract

Cardiac surgery in patients with preexisting bleeding disorders can be a challenge. Cardiopulmonary bypass can lead to bleeding disorders, above all in patients with coagulopathy. We report the case of a 42-year-old woman, with type I von Willebrand disease, who underwent off-pump coronary artery bypass grafting. Beating heart surgery associated with an adequate replacement of von Willebrand factor and factor VIII levels were chosen to prevent bleeding disorders. Her postoperative course was uneventful and she was discharged home after 5 postoperative days.

 
  • References

  • 1 Mannucci PM. Treatment of von Willebrand's disease. J Intern Med Suppl 1997; 740: 129-132
  • 2 Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21 (2) 232-244
  • 3 Chassot PG, van der Linden P, Zaugg M, Mueller XM, Spahn DR. Off-pump coronary artery bypass surgery: physiology and anaesthetic management. Br J Anaesth 2004; 92 (3) 400-413 Review
  • 4 Pantely GA, Goodnight Jr SH, Rahimtoola SH , et al. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. N Engl J Med 1979; 301 (18) 962-966
  • 5 Gohlke H, Gohlke-Bärwolf C, Stürzenhofecker P , et al. Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: a prospective, randomized study. Circulation 1981; 64 (2 Pt 2) II22-II27
  • 6 McEnany MT, Salzman EW, Mundth ED , et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. J Thorac Cardiovasc Surg 1982; 83 (1) 81-89
  • 7 Pruthi RK. A practical approach to genetic testing for von Willebrand disease. Mayo Clin Proc 2006; 81 (5) 679-691
  • 8 Federici AB. Clinical diagnosis of von Willebrand disease. Haemophilia 2004; 10 (Suppl. 04) 169-176
  • 9 Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 2008; 117 (11) 1449-1459
  • 10 Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76 (9) 1680-1697
  • 11 Komp DM, Nolan SP, Carpenter MA. Open-heart surgery in a patient with von Willebrand's disease. J Thorac Cardiovasc Surg 1970; 59 (2) 225-230
  • 12 Aris A, Pisciotta AV, Hussey CV, Gale H, Lepley D. Open-heart surgery in von Willebrand's disease. J Thorac Cardiovasc Surg 1975; 69 (2) 183-187